% | $
Quotes you view appear here for quick access.

Integra LifeSciences Holdings Corporation Message Board

  • xinyalu2012 xinyalu2012 Jan 10, 2012 10:54 AM Flag

    Oppenheimer maintains an Outperform

    Integra LifeSciences Holdings Corporation (NASDAQ:IART): Oppenheimer lowers Integra LifeSciences target from $43 to $32, citing lower than expected fiscal year 2011 earnings-per-share and receipt of a Food and Drug Administration(FDA) warning letter. Oppenheimer feels “meaningful strides” have been taken with FDA’s issues whcih appear short-term. Oppenheimer maintains an Outperform.

56.19-1.42(-2.46%)10:10 AMEST